Myriad Settles With Quest In Cancer Gene Test Patent MDL

By Daniel Siegal (February 6, 2015, 10:01 PM EST) -- Myriad Genetics Inc. on Friday settled patent infringement litigation with Quest Diagnostics Inc., dismissing claims in Utah federal court alleging Quest infringed Myriad's patents for BRCA cancer gene testing, some of which had been recently invalidated by the Federal Circuit....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!